Search
for
Sort by
Research 121–150 of 1000+
- A Population of Radio-Resistant Macrophages in the Deep Myenteric Plexus Contributes to Postoperative Ileus Via Toll-Like Receptor 3 Signaling
- Are Women with Polycystic Ovary Syndrome at Increased Risk of Alzheimer Disease? Lessons from Insulin Resistance, Tryptophan and Gonadotropin Disturbances and Their Link with Amyloid-Beta Aggregation
- Progress of ursolic acid on the regulation of macrophage: summary and prospect
- Exploring the Antioxidative Effects of Ginger and Cinnamon: A Comprehensive Review of Evidence and Molecular Mechanisms Involved in Polycystic Ovary Syndrome (PCOS) and Other Oxidative Stress-Related Disorders
- Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
- Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- Polycystic ovary syndrome and its management: In view of oxidative stress
- The effects of pro-, pre-, and synbiotics supplementation on polycystic ovary syndrome: an umbrella review of meta-analyses of randomized controlled trials
- Metabolic Syndrome, Hepatic Steatosis and Testosterone: A Matter of Sex
- The Silent Syndrome of Long COVID and Gaps in Scientific Knowledge: A Narrative Review
- Quercetin and polycystic ovary syndrome
- Comparative advantage and efficacy of natural products for polycystic ovary syndrome
- Immunological and Metabolic Causes of Infertility in Polycystic Ovary Syndrome
- Harnessing Microbiome, Bacterial Extracellular Vesicle, and Artificial Intelligence for Polycystic Ovary Syndrome Diagnosis and Management
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Refractory/relapse thrombocytopenia in a patient with Evans' syndrome successfully treated with zanubrutinib
- Macrophage-Centric Immunometabolic Crosstalk in Alopecia Areata Pathogenesis: Mechanisms and Therapeutic Implications
- The Implication of Mechanistic Approaches and the Role of the Microbiome in Polycystic Ovary Syndrome (PCOS): A Review
- Modern Polycystic Ovary Syndrome (PCOS) Management: Intelligent Drug Delivery and Metabolic Reprogramming for Ovarian Restoration and Fertility Optimization
- Common Skin Diseases and Metabolic Syndrome: A Proinflammatory Chemokine Perspective
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
- Mitochondrial dysfunction in metabolic syndrome and inflammatory skin disease
- POST-FINASTERIDE SYNDROME AND POST-SSRI SEXUAL DYSFUNCTION: TWO CLINICAL CONDITIONS APPARENTLY DISTANT, BUT VERY CLOSE
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- Metabolic syndrome and dermatological diseases: association and treatment
- Post-COVID-19 Syndrome: The Persistent Symptoms at the Post-viral Stage of the Disease. A Systematic Review of the Current Data
- Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation
- Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome
- Hutchinson-Gilford Progeria Syndrome—Current Status and Prospects for Gene Therapy Treatment